Your browser doesn't support javascript.
loading
Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma.
Mitra, Akash; Andrews, Miles C; Roh, Whijae; De Macedo, Marianna Petaccia; Hudgens, Courtney W; Carapeto, Fernando; Singh, Shailbala; Reuben, Alexandre; Wang, Feng; Mao, Xizeng; Song, Xingzhi; Wani, Khalida; Tippen, Samantha; Ng, Kwok-Shing; Schalck, Aislyn; Sakellariou-Thompson, Donald A; Chen, Eveline; Reddy, Sangeetha M; Spencer, Christine N; Wiesnoski, Diana; Little, Latasha D; Gumbs, Curtis; Cooper, Zachary A; Burton, Elizabeth M; Hwu, Patrick; Davies, Michael A; Zhang, Jianhua; Bernatchez, Chantale; Navin, Nicholas; Sharma, Padmanee; Allison, James P; Wargo, Jennifer A; Yee, Cassian; Tetzlaff, Michael T; Hwu, Wen-Jen; Lazar, Alexander J; Futreal, P Andrew.
Afiliación
  • Mitra A; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Andrews MC; Quantitative Sciences Graduate Training Program, Graduate School of Biomedical Sciences, Houston, Texas, USA.
  • Roh W; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • De Macedo MP; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia.
  • Hudgens CW; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Carapeto F; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Singh S; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Reuben A; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang F; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mao X; Department of Thoracic Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Song X; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wani K; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tippen S; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ng KS; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Schalck A; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sakellariou-Thompson DA; Institute for Personalized Cancer Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chen E; Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Reddy SM; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Spencer CN; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wiesnoski D; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Little LD; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
  • Gumbs C; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cooper ZA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Burton EM; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hwu P; AstraZeneca, Gaithersburg, Maryland, USA.
  • Davies MA; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhang J; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bernatchez C; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Navin N; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sharma P; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Allison JP; Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wargo JA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yee C; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tetzlaff MT; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hwu WJ; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lazar AJ; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Futreal PA; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
Nat Commun ; 11(1): 1839, 2020 04 15.
Article en En | MEDLINE | ID: mdl-32296058
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Genómica / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Genómica / Melanoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos